Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Receivables: 2011-2025

Historic Receivables for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $40.1 million.

  • Mesa Laboratories' Receivables fell 0.35% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.1 million, marking a year-over-year increase of 8.10%. This contributed to the annual value of $42.0 million for FY2025, which is 7.46% up from last year.
  • As of Q3 2025, Mesa Laboratories' Receivables stood at $40.1 million, which was up 2.62% from $39.1 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Receivables ranged from a high of $42.6 million in Q1 2023 and a low of $20.6 million during Q2 2021.
  • Its 3-year average for Receivables is $39.0 million, with a median of $39.1 million in 2025.
  • Its Receivables has fluctuated over the past 5 years, first spiked by 103.32% in 2022, then dropped by 15.03% in 2023.
  • Over the past 5 years, Mesa Laboratories' Receivables (Quarterly) stood at $37.3 million in 2021, then climbed by 13.69% to $42.4 million in 2022, then decreased by 15.03% to $36.0 million in 2023, then grew by 16.51% to $42.0 million in 2024, then decreased by 0.35% to $40.1 million in 2025.
  • Its Receivables stands at $40.1 million for Q3 2025, versus $39.1 million for Q2 2025 and $42.0 million for Q1 2025.